NCT03820479 is a clinical trial of Protocol in Quality of Recovery, sponsored by Danderyd Hospital.

Who is sponsoring NCT03820479?

NCT03820479 is sponsored by Danderyd Hospital.

What drugs are being tested in NCT03820479?

Interventions in NCT03820479: Protocol.

What condition does NCT03820479 study?

NCT03820479 studies Quality of Recovery.

Is NCT03820479 still recruiting?

NCT03820479 is currently completed. Last updated 10 July 2025.

Last reviewed 2025-07-10 · How we verify

NCT03820479

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Investigate Quality of Recovery up to Day 7 in Females Undergoing Laparoscopic Abdominal Surgery Provided Apfel-score Based PONV Care and Prophylaxis

Completed Last updated 10 July 2025

What this trial tests

trial testing Protocol in Quality of Recovery in 98 participants. Completed in 15 May 2024.

Timeline

11 February 2019

Primary endpoint
28 February 2024

15 May 2024

Quick facts

Lead sponsor	Danderyd Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	98
Start date	11 February 2019
Primary completion	28 February 2024
Estimated completion	15 May 2024
Sites	1 location across Sweden

Drugs / interventions tested

Protocol

Conditions studied

Quality of Recovery — all drugs for Quality of Recovery →

Sponsor

Danderyd Hospital

Who can join

Adults 18 to 75, female only, with Quality of Recovery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SYNOPSIS Title: An observational study to investigate Quality of Recovery and the incidence and impact of Post-Operative Nausea and Vomiting (PONV)/Post-Discharge Nausea and Vomiting (PDNV) and up to 7 days in females undergoing laparoscopic abdominal surgery provided Apfel-score based PONV care and prophylaxis. Study period: September 2018- September 2019 Hypothesis: When a high risk patient, Apfel-score 3 or 4, is given Apfel-score based PONV care with strict adherence to PONV guidelines there should be no difference in Quality of Recovery between a high-risk patient and a low-risk patient. Aim: The aim of the study is to investigate if it is possible to reach no difference in Quality of Recovery (QoR) between a high-risk patient and a low risk patient using Apfel-score based PONV care. Primary objective: Assessing Quality of Recovery, using QoR15 at 24h, 48h, 72h and after 7 days. Secondary objectives: Assessing the incidence and severity of PONV and PDNV in females undergoing laparoscopic surgery up to 72h. Assessing PONV and PDNV severity and duration. Nicotine habits and impact on PONV. Study outline: Females scheduled for elective abdominal laparoscopic surgery will be provided PONV care based on Apfel risk-score. All patients will fill in the QoR15 form before surgery (base line). PONV and PDNV will be assessed in the PACU postoperatively, after 24h, 48h and 72h. Quality of Recovery will be assessed up to 7 days after surgery. Treatment: The females will be given ordinary care after local routines, with strict adherence to PONV guidelines. Study population: 100 females aged 18-65, ASA 1-2, undergoing laparoscopic abdominal surgery in Danderyds Hospital. Primary outcome variables and examinations: When the QoR 15 reaches base line or better after surgery. Number of times the females experience nausea, retching or vomiting and the impact of emetic symptoms on the QoR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Quality of Recovery

Currently open trials in the same condition.

NCT06584825 — Enhanced Vitals Monitoring After Major Surgery Trial · NA · recruiting
NCT06948383 — SPSIPB vs. SAPB in Breast Surgery · NA · active not recruiting

Other Danderyd Hospital trials

Trials by the same sponsor.

NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
NCT06346145 — Impact of Bariatric Surgery on Heart Disease Compared to Standard Care · NA · not yet recruiting
NCT07476703 — Expanded Studies on the SCAPIS Stockholm Reexamination Cohort · recruiting
NCT05359367 — A Novel Approach to Enhance True Recovery After Stroke · terminated
NCT06734247 — Arterial Stiffness for Improved Prediction of Coronary Artery Disease by Coronary CT Angiography · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03820479 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danderyd Hospital
Last refreshed: 10 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03820479.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing